Masahiko Mihara

7.5k total citations · 1 hit paper
99 papers, 6.2k citations indexed

About

Masahiko Mihara is a scholar working on Immunology, Rheumatology and Oncology. According to data from OpenAlex, Masahiko Mihara has authored 99 papers receiving a total of 6.2k indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Immunology, 32 papers in Rheumatology and 25 papers in Oncology. Recurrent topics in Masahiko Mihara's work include Cytokine Signaling Pathways and Interactions (16 papers), Rheumatoid Arthritis Research and Therapies (15 papers) and T-cell and B-cell Immunology (13 papers). Masahiko Mihara is often cited by papers focused on Cytokine Signaling Pathways and Interactions (16 papers), Rheumatoid Arthritis Research and Therapies (15 papers) and T-cell and B-cell Immunology (13 papers). Masahiko Mihara collaborates with scholars based in Japan, United States and India. Masahiko Mihara's co-authors include Misato Hashizume, Yoshiyuki Ohsugi, Miho Suzuki, Masashi Shiina, Tadamitsu Kishimoto, Hiroto Yoshida, Naohiko Hayakawa, Y Ohsugi, Yoichiro Moriya and Norihiro Nishimoto and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Clinical Investigation.

In The Last Decade

Masahiko Mihara

99 papers receiving 6.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

IL-6/IL-6 receptor system and its role in physiological and pathological conditions

2011 686 citations Masahiko Mihara, Misato Hashizume et al. profile →

Peers

Countries citing papers authored by Masahiko Mihara

Since Specialization

Citations

This map shows the geographic impact of Masahiko Mihara's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Masahiko Mihara with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Masahiko Mihara more than expected).

Fields of papers citing papers by Masahiko Mihara

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Masahiko Mihara. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Masahiko Mihara. The network helps show where Masahiko Mihara may publish in the future.

Co-authorship network of co-authors of Masahiko Mihara

This figure shows the co-authorship network connecting the top 25 collaborators of Masahiko Mihara. A scholar is included among the top collaborators of Masahiko Mihara based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Masahiko Mihara. Masahiko Mihara is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Blockade of IL-6 and TNF-α inhibited oxLDL-induced production of MCP-1 via scavenger receptor induction 2012 ·European Journal of Pharmacology ·Misato Hashizume, Masahiko Mihara	41
2	Instability of Foxp3 Expression Limits the Ability of Induced Regulatory T Cells to Mitigate Graft versus Host Disease 2011 ·Clinical Cancer Research ·Amy Beres, Richard Komorowski, Masahiko Mihara, William R. Drobyski	73
3	Anti-IL-6 Receptor Antibody Causes Less Promotion of Tuberculosis Infection than Anti-TNF- Antibody in Mice 2011 ·SHILAP Revista de lepidopterología ·Masaji Okada, Yoko Kita, Noriko Kanamaru, Satomi Hashimoto, Yasushi Uchiyama, Masahiko Mihara, Yoshikazu Inoue, Yoshiyuki Ohsugi, Tadamitsu Kishimoto, Mitsunori Sakatani	20
4	Tocilizumab, a humanized anti-interleukin-6 receptor antibody, for treatment of rheumatoid arthritis 2011 ·Open Access Rheumatology Research and Reviews ·Masahiko Mihara, Yoshiyuki Ohsugi, (unknown)	40
5	IL-6 plays an essential role in neutrophilia under inflammation 2011 ·Cytokine ·Misato Hashizume, Yoshinobu Higuchi, Yasushi Uchiyama, Masahiko Mihara	70
6	Comparative analysis of the effects of anti-IL-6 receptor mAb and anti-TNF mAb treatment on CD4+ T-cell responses in murine colitis 2010 ·Inflammatory Bowel Diseases ·Fumitaka Terabe, Minoru Fujimoto, Satoshi Serada, Shinichiro Shinzaki, Hideki Iijima, Masahiko Tsujii, Norio Hayashi, Shintaro Nomura, Hirohisa Kawahata, Myoung Ho Jang, Masayuki Miyasaka, Masahiko Mihara, Yoshiyuki Ohsugi, Tadamitsu Kishimoto, Tetsuji Naka	14
7	Induction of high-dose tolerance to the rat anti-mouse IL-6 receptor antibody in NZB/NZW F1 mice 2010 ·Rheumatology International ·Hiroto Yoshida, Misato Hashizume, Miho Suzuki, Masahiko Mihara	16
8	High molecular weight hyaluronic acid relieved joint pain and prevented the progression of cartilage degeneration in a rabbit osteoarthritis model after onset of arthritis 2010 ·Modern Rheumatology ·Misato Hashizume, Nobuo Koike, Hiroto Yoshida, Miho Suzuki, Masahiko Mihara	31
9	IL-6 blockade preferentially inhibits Th17 differentiation in collagen-induced arthritis 2010 ·Rheumatology International ·Hiroto Yoshida, Misato Hashizume, Masahiko Mihara	19
10	Blockade of interleukin-6 signaling augments regulatory T-cell reconstitution and attenuates the severity of graft-versus-host disease 2009 ·Blood ·Xiaohong Chen, Rupali Das, Richard Komorowski, Amy Beres, Martin J. Hessner, Masahiko Mihara, William R. Drobyski	230
11	Comparison of effects of alfacalcidol and alendronate on mechanical properties and bone collagen cross-links of callus in the fracture repair rat model 2009 ·Bone ·Mitsuru Saito, Ayako Shiraishi, Masako Ito, Sadaoki Sakai, Naohiko Hayakawa, Masahiko Mihara, Keishi Marumo	39
12	Evidence for the role of Th17 cell inhibition in the prevention of autoimmune diseases by anti‐interluekin‐6 receptor antibody 2009 ·BioFactors ·Masahiko Mihara, Yoshiyuki Ohsugi, Tadamitsu Kishimoto	26
13	Crucial role of the interleukin‐6/interleukin‐17 cytokine axis in the induction of arthritis by glucose‐6‐phosphate isomerase 2008 ·Arthritis & Rheumatism ·Keiichi Iwanami, Isao Matsumoto, (unknown), Asuka Inoue, Masahiko Mihara, Yoshiyuki Ohsugi, Mizuko Mamura, Daisuke Goto, Satoshi Ito, Akito Tsutsumi, Tadamitsu Kishimoto, Takayuki Sumida	113
14	Anti-IL-6 receptor antibody increases blood IL-6 level via the blockade of IL-6 clearance, but not via the induction of IL-6 production 2008 ·International Immunopharmacology ·Yasushi Uchiyama, Hiroto Yoshida, Nobuo Koike, Naohiko Hayakawa, Atsuko Ikenouchi, Takashi Nishimura, Masahiko Mihara	39
15	Tocilizumab inhibits signal transduction mediated by both mIL-6R and sIL-6R, but not by the receptors of other members of IL-6 cytokine family 2005 ·International Immunopharmacology ·Masahiko Mihara, (unknown), Makoto Okazaki, Akito Nakamura, Shigeto Kawai, Masamichi Sugimoto, Yoshihiro Matsumoto, Yoshiyuki Ohsugi	258
16	A Resorcylic Acid Lactone, 5Z-7-Oxozeaenol, Prevents Inflammation by Inhibiting the Catalytic Activity of TAK1 MAPK Kinase Kinase 2003 ·Journal of Biological Chemistry ·Jun Ninomiya‐Tsuji, Taisuke Kajino, Koichiro Ono, Toshihiko Ohtomo, Masahiko Matsumoto, Masashi Shiina, Masahiko Mihara, Masayuki Tsuchiya, Kunihiro Matsumoto	355
17	Mechanism of Action of Combined Short-Term CTLA4Ig and Anti-CD40 Ligand in Murine Systemic Lupus Erythematosus 2002 ·The Journal of Immunology ·Xiaobo Wang, Weiqing Huang, Masahiko Mihara, Jayashree Sinha, Anne Davidson	83
18	CTLA4Ig inhibits T cell–dependent B-cell maturation in murine systemic lupus erythematosus 2000 ·Journal of Clinical Investigation ·Masahiko Mihara, Irene Tan, (unknown), (unknown), (unknown), Aton M. Holzer, (unknown), Anne Davidson	131
19	Preventive effect of a novel antifolate, MX-68, in murine systemic lupus erythematosus (SLE) 1997 ·International Journal of Immunopharmacology ·Masahiko Mihara, Nobuhiro Takagi, (unknown), Yoichiro Moriya, Yasuhisa Takeda	3
20	An immunomodulating anti-rheumatic drug, lobenzarit disodium (CCA): Inhibition of polyclonal B-cell activation and prevention of autoimmune disease in MRL/Mp-lpr/lpr mice 1987 ·Clinical Immunology and Immunopathology ·Masahiko Mihara, Toshiaki Nakano, Yoshiyuki Ohsugi	12

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact